MLYCD and clear cell renal carcinoma: The key regulatory factor of fatty acid synthesis metabolism, malonyl CoA decarboxylase (MLYCD), is significantly downregulated in renal clear cell carcinoma, and low expression is associated with poor prognosis in patients.